Jennifer Doudna's Next CRISPR Goals

Jennifer Doudna, the Nobel laureate, raised concerns about the cost and access issues of the first CRISPR-based therapy, which is expected to gain approval soon. She emphasized the need to ensure that the technology has a broad, real-world impact and not just benefit a few people.